Ganglioside GM1 attenuates scopolamine-induced amnesia in rats and mice

Psychopharmacology

Volumn 141, Issue 2, 1999, Pages 111-117

  Silva, R H ^a   Felicio, L F ^b   Frussa Filho, R ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Learning; Memory; Monosialoganglioside; Scopolamine

Indexed keywords

GANGLIOSIDE GM1; SCOPOLAMINE;

AMNESIA; ANIMAL EXPERIMENT; ARTICLE; AVERSION; CHOLINERGIC SYSTEM; CHOLINERGIC TRANSMISSION; CONTROLLED STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; LEARNING; MALE; MEMORY; MOUSE; NONHUMAN; OUTCOMES RESEARCH; PASSIVE AVOIDANCE; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM;

AMNESIA; ANALYSIS OF VARIANCE; ANIMALS; AVOIDANCE LEARNING; DISCRIMINATION LEARNING; G(M1) GANGLIOSIDE; LEARNING; MALE; MAZE LEARNING; MEMORY; MICE; RATS; RATS, WISTAR; SCOPOLAMINE;

EID: 0032925298     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050814     Document Type: Article

References (57)

1. Agnati LF, Fuxe K, Benfenati F, Batistini N, Zini I, Toffano G (1983a) Chronic ganglioside treatment counteracts the biochemical signs of dopamine receptor supersensitivity induced by chronic haloperidol treatment. Neurosci Lett 40:293-297
2. Agnati LF, Fuxe K, Calza L, Benfenati F, Cavecchioli L, Toffano G, Goldstein M (1983b) Gangliosides increase the survival of lesioned nigral dopamine neurons and favor the recovery of dopaminergic synaptic function in striatum of rats by colateral sprouting. Acta Physiol Scand 119: 347-363
3. Aigner TG (1995) Pharmacology of memory: cholinergic-glutamatergic interactions. Curr Opin Neurobiol 5: 155-160
4. Bellot RG, Camarini R, Vital MABF, Palermo-Neto J, Leyton V, Frussa-Filho R (1996) Monosialoganglioside attenuates the excitatory and behavioural sensitization effects of ethanol. Eur J Pharmacol 313: 175-179
5. Bellot RG, Vital MABF, Palermo-Neto J, Frussa-Filho R (1997) Repeated monosialoganglioside administration attenuates behavioral sensitization to amphetamine. Brain Res 747: 169-172
6. Casamenti F, Bracco L, Bartolini L, Pepeu G (1985) Effects of ganglioside treatment in rats with a lesion of the cholinergic forebrain nuclei. Brain Res 338:45-52
7. +. J Neurosci 13: 3104-3111
8. 2+ dynamics after toxic doses of glutamate in cerebellar granule cells. Proc Natl Acad Sci USA 87: 8017-8021
9. Denti A, Epstein A (1972) Sex differences in the acquisition of two kinds of avoidance behaviour in rats. Physiol Behav 8:611-615
10. Di Patre PL, Abbamondi A, Bartolini L, Pepeu G (1989) GM1 ganglioside counteracts cholinergic and behavioral deficits induced in the rat by intracerebral injection of vincristine. Eur J Pharmacol 162: 43-50
11. Dunbar GL, Lescaudron LL, Stein DG (1993) Comparison of GM1 ganglioside, AGF2 and D-amphetamine as treatments for spatial reversal and place learning deficits following lesions of the neostriatum. Behav Brain Res 54: 67-79
12. Dunn A, Entingh D, Entingh T, Gispen WH, Machlus B, Perumal R, Rees HD, Brogan L (1974) Biochemical correlates of brief behavioral experiences. In: Schimidt FO, Warden FG (eds) The neurosciences: third study program. MIT Press, Cambridge, pp 679-684
13. Ebel A, Hermelt JC, Mandel P (1973) Comparative study of acetylcholinesterase and choline acetyltransferase enzyme activity in brain of DBA and C57 mice. Nature New Biol 242: 56-58
14. Elliot PJ, Garofalo L, Cuello AC (1989) Limited neocortical devascularizing lesions causing deficits in memory retention and choline acetyltransferase activity - effects of the monosialoganglioside GM1. Neuroscience 31: 63-67
15. Fagioli S, Castellano, C, Oliverio A, Toffano G (1990) Effect of chronic GM1 ganglioside administration on passive avoidance retention in mice. Neurosci Lett 109:212-216
16. Fagioli S, Rossi-Arnaud C, Amassari-Teule M (1991) Open-field behaviours and spatial learning performance in C57BL/6 mice: early stage effects of chronic ganglioside administration. Psychopharmacology 105:209-212
17. Fagioli S, Rossi-Arnaud C, Castellano, C (1992) Dose-dependent effect of GM1 ganglioside during development on inhibitory avoidance behaviour in mice in mice: influence of period of administration. Psychopharmacology 109: 457-460
18. Favaron M, Manev H, Alho H, Bertolino M, Ferret B, Guidotti A, Costa E (1988) Gangliosides prevent glutamate and kainate neurotoxicity in primary neuronal cultures of neonatal rat cerebellum and cortex. Proc Natl Acad Sci USA 86: 7351-7355
19. Fong TG, Neff NH, Hadjiconstantinou M (1995) Systemic administration of GM1 ganglioside increases choline acetyltransferase activity in the brain of aged rats. Exp Neurol 132: 157-161
20. Fong TG, Neff NH, Hadjiconstantinou M (1997) GM1 ganglioside improves spatial learning and memory of aged rats. Behav Brain Res 85: 203-211
21. Gage FH, Chen KS, Buzsaki G, Armstrong D (1988) Experimental approaches to age-related cognitive impairments. Neurobiol Aging 9:645-655
22. Garofalo L, Cuello AC (1994) Nerve growth factor and the monosialoganglioside GM1: analogous and different in vivo effects on biochemical, morphological and behavioural parameters of adult cortically lesioned rats. Exp Neurol 125: 195-217
23. Hadjiconstantinou M, Neff, NH (1988) Treatment with GM1 ganglioside restores striatal dopamine in the 1-methyl-4-phenyl-1,2,3,6,-tetrahydropyridine-treated mouse. J Neurochem 51: 1190-1196
24. Hadjiconstantinou M, Karadsheh NS, Rattan AK, Tejwani GA, Fitkin JG, Neff, NH (1992) GM1 ganglioside enhances cholinergic parameters in the brain of senescent rats. Neuroscience 46:681-686
25. Hefti F, Hartikka J, Knusel B (1989) Function of neurotrophic factors in the adult and aging brain and their possible use in the treatment of neurodegenerative diseases. Neurobiol Aging 10:515-533
26. Hersi AI, Rowe W, Gaudreau P, Quirion R (1995) Dopamine D1 receptor ligands modulate cognitive performance and hippocampal acetylcholine release in memory-impaired aged rats. Neuroscience 69:1067-1074
27. Joseph JA, Berger RE, Engle BT, Roth GS (1978) Age-related changes in the neostriatum: a behavioral and biochemical analysis. J Gerontol 33:643-649
28. Karpiak SE, Rapport MM (1979) Inhibition of consolidation and retrieval stage of passive avoidance learning by antibodies to gangliosides. Behav Neurol Biol 27:146-156
29. Karpiak SE, Graf L, Rapport MM (1978) Antibodies to GM1 ganglioside inhibit a learned avoidance response. Brain Res 151: 637-640
30. 2 antagonists on radial maze performance in rats. Behav Neural Biol 50: 240-245
31. Lipartiti M, Lazzaro A, Zanoni R, Mazzari S, Toffano G, Leon A (1991) Monosialoganglioside GM1 reduces NMDA neurotoxicity in neonatal rat brain. Exp Neurol 113: 301-305
32. Lombardi G, Moroni F (1992) GM1 ganglioside reduces inschemia-induced excitatory amino acid output: a microdialysis study in the gerbil hippocampus. Neurosci Lett 134: 171-174
33. Mahadik SP, Mukherjee S (1995) Monosialoganglioside cotreatment prevents haloperidol treatment-associated loss of cholinergic enzymes in rat brain. Biol Psychiatry 38: 246-254
34. Maysinger D, Herrera-Marschitz M, Carlsson A, Garofalo L, Cuello AC, Ungerstedt U (1988) Striatal and cortical acetylcholine release in vivo in rats with unilateral decortication: effects of treatment with monosialoganglioside GM1. Brain Res 461: 355-360
35. Maysinger D, Herrera-Marschitz M, Ungerstedt U, Cuello AC (1990) Acetylcholine release in vivo: effects of crhonic treatment with monosialoganglioside GM1. Neuropharmacology 29: 151-159
36. Maysinger D, Leavitt BR, Zorc B, Butula I, Fernandes LG, Ribeiro-da-Silva A (1992) Inhibition of high-affinity choline uptake in the rat brain by neurotoxins: effect of monosialoganglioside GM1. Neurochem Int 20: 289-297
37. McGurk SR, Levin ED, Butcher LL (1988) Cholinergic-dopaminergic interactions in radial-arm maze performance. Behav Neural Biol 49:234-239
38. Nistri A, Bartolini A, Deferru G, Pepeu G (1972) Investigation into the release of acetylcholine from the cerebral cortex of the cat: effects of amphetamine, of scopolamine and of septal lesions. Neuropharmacology 11:665-670
39. Oderfeld-Nowak B, Wojcik M, Vlas J, Potempska A (1981) Effects of chronic ganglioside treatment on recovery processes in hippocampus after brain lesions in rats. In: Rapport MM, Gorio A (eds) Gangliosides in neurobiological and neuromuscular function, development and repair. Raven Press, New York, pp 197-209
40. Oderfeld-Nowak B, Skup M, Ulas J, Jezierska M, Gradkowska M, Zaremba M (1984) Effect of GM1 ganglioside treatment on post lesion responses of cholinergic enzymes in rat hippocampus after various partial deafferations. J Neurosci Res 12: 409-420
41. Poplawsky A, Isaacson RL (1987) The GM1 ganglioside hastens the reduction of hyperemotionality after septal lesions. Behav Neurol Biol 48:156-158
42. Rahmann H (1986) Brain gangliosides: neuromodulators for synaptic transmission and memory formation. In: Matthies H (ed) Advances in the biosciences 59. Pergamon Press, Oxford, pp 235-245
43. Ramirez J, Fass B, Kilfoil T, Henschel B, Grones W, Karpiak SE (1987) Ganglioside-induced enhancement of behavioral recovery after bilateral lesions of the entorhinal cortex. Brain Res 414:85-90
44. Rapport MM (1981) Introduction to the biochemistry of gangliosides. In: Rapport MM, Gorio A (eds) Gangliosides in neurobiological and neuromuscular function, development and repair. Raven Press, New York, pp 15-19
45. Roth GS, Joseph JA (1994) Age-related changes in transcriptional and posttranscriptional regulation of the dopaminergic system. Life Sci 55: 2031-2035
46. Sabel BA, Slavin MD, Stein DG (1984) GM1 ganglioside treatment facilitates behavioural recovery from bilateral brain damage. Science 225:340-342
47. Schroder U, Schroder H, Augustin W, Sabel BA (1994) Haloperidol induced behavioral supersensitivity is increased by monosialoganglioside treatment in rats without affecting spiroperidol-binding. J Pharmacol Exp Ther 271: 1193-1196
48. Seifert W, Wierasko A, Terlau H, Hollmann M (1987) Gangliosides and neuronal plasticity in the hippocampus. NATO ASI Series H 7:523-528
49. Silva RH, Felicio LF, Nasello AG, Vital MABF, Frussa-Filho R (1996) Effects of ganglioside (GM1) on memory in senescent rats. Neurobiol Aging 17:582-586
50. Silva RH, Bellot RG, Vital MABF, Frussa-Filho R (1997) Effects of long-term ganglioside GM1 administration on a new discriminative avoidance test in normal adult mice. Psychopharmacology 129:322-328
51. Steele TD, Hodges Jr DB, Levesque TR, Locke KW, Sandage Jr BW (1996) Ann NY Acad Sci 17: 427-430
52. Tanaka Y, Ando S (1996) Modulation of cholinergic synaptic functions by sialylcholesterol. Glycoconj J 13: 321-326
53. Tettamanti G, Sonnino S, Ghiondi R, Masserini M, Venerando B (1985) Chemical and functional properties of gangliosides. Their possible implication in the membrane mediated transfer of information. In: Physics and amphiphiles: miscelles, vesicles and microemulsions. XC Corso Soc. Ital. Fisica, Bologna, pp 607-636
54. Toffano G, Agnati LF, Fuxe KG (1986) The effect of the ganglioside GM1 on neuronal plasticity. Int J Dev Neurosci 4: 97-100
55. Vital MABF, Frussa-Filho R, Palermo-Neto J (1995) Effects of monosialogangloside on dopaminergic supersensitivity. Life Sci 56: 2299-2307
56. Vital MABF, Frussa-Filho R, Palermo-Neto J (1997) Effects of monosialoganglioside on a new model of tardive dyskinesia. Prog Neuropharmacol Biol Psychiatry 21: 1169-1179
57. Wojcik M, Ulas J; Oderfeld-Nowak B (1982) The stimulating effect of ganglioside injections on the recovery of choline acetyltransferase and acetylcholinesterase activities in the hippocampus of the rat after septal lesions. Neuroscience 7: 495-499